Boards

The CBC is supported by academic leaders from Northwestern University, The University of Chicago, and the University of Illinois Chicago (UIC). In addition to leadership, our board membership includes interdisciplinary advisors outside of the CBC’s member institutions. The CBC boards meet regularly to discuss CBC initiatives, award and educational programs, and strategies.

Executive Oversight Board

Erin J. Adams, PhD
Vice Provost for Research & Senior Research Officer
The University of Chicago
Joanna Groden, PhD
Vice Chancellor for Research
University of Illinois Chicago
Eric J. Perreault, PhD
Vice President for Research
Northwestern University


Accelerator Venture Board

2Flo Ventures Bessemer Venture Partners J&J Innovation Phase Capital
AbbVie Ventures Breakout Ventures KdT Ventures Portal Innovations
Abingworth Cincytech Bio Laerdal Million Lives Fund Qral Group
Agent Capital Deep Work Capital Luma Group Smarthealth Catalyzer
ARCH Venture Partners Deerfield MPM Capital Undettered Capital
Astellas Eli Lilly MRL Ventures Fund Venture Investors
Astra Zeneca Illinois Ventures Orbimed Xeris Pharma
Atlas Ventures Indie Bio PACE Healthcare Capital Xontongeny
Bain Capital Insight Partners Pathway Bioventures Zeal Capital Partners


Ad Hoc Science Board** (triage review)

AbbVie
  James Kath, PhD
  Steve Elmore, PhD
Agent Capital
  Vissaagan Gopalakrishnan, MD
Flare Therapeutics
  Jim Audia, PhD
Janssen R&D
  Michael Bemben, PhD
Mayo Clini
  Svetomir Markovic, MD, PhD
OrbiMed
  Jim Sullivan, PhD
Portal Innovations
  Yuan Zhang, PhD, MS
Rush University Medical Center
  Annabelle Santos Volgman, MD
Sernova
  Modestus Obochi, PhD, MBA
Northwestern University
  Amy Heimberger, MD
  Evan Scott, PhD
  Lisa Dhar, PhD
  Priya U Kumthekar, MD
  Satish Nadig, MD, PhD
The University of Chicago
  Diana Bolotin MD, PhD
  Jeff Hubbell, PhD
  Kay McLeod, PhD
  Kunal Desai, MD, MBA
  Raghu Mirmira, MD, PhD
  Savas Tay, PhD
  Scott Oakes, MD
University of Illinois Chicago
  Brian Layden, MD, PhD
  Joanna Burdette, PhD
  Terry Moore, PhD
SV Health Investors
  Jim Summers, PhD

**in addition to the ad hoc panel listed here, we engage domain experts during each ad hoc committee meeting, depending on the therapeutic focus of the applications under review.



back to top